Overview

IAMA-6 Oral Dose Study in Healthy Adults

Status:
RECRUITING

Trial end date:
2024-09-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of IAMA-6 administered orally to healthy adults.

Phase:

PHASE1

Details

Lead Sponsor:

Iama Therapeutics S.r.l.